<?xml version="1.0" encoding="UTF-8"?>
<p>Exposure to PG in new-borns and children under 4 years of age remains common, despite historical and contemporary reports dealing with toxic adverse effects of this excipient. Thus, the study of Allegaert J. [
 <xref rid="B33-pharmaceutics-13-00387" ref-type="bibr">33</xref>] in terms of the PG research project in new-borns is of great interest, as it provides scientific evidence on the tolerance and plasma clearance of this excipient, including differences in elimination pathways (renal pathway compared to the hepatic pathway).
</p>
